Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04710719 · ClinicalTrials.gov registry record · NA
Post-Surgical Injection With Triamcinolone Versus Triamcinolone/Fluorouracil in Treatment of Keloids
A NA study, sponsored by Our Lady of the Lake Hospital.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04710719: Completed NA study, sponsored by Our Lady of the Lake Hospital.
NCT04710719 is a NA study that has completed, run by Our Lady of the Lake Hospital. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04710719, a NA study, has completed, sponsored by Our Lady of the Lake Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
There have been many modalities utilized in the treatment of keloids of the head and neck, however none have been universally successful. The most widely utilized non-surgical intervention is primary intralesional injection with triamcinolone (TAC) which inhibits the proliferation of fibroblasts, inhibits collagen synthesis, and increases collagenase production, or fluorouracil (5-FU), a potent inhibitor of fibroblast proliferation. Despite the abundance of studies evaluating primary intralesional injection for keloids, there are limited studies available regarding the efficacy of primary surgical excision followed by adjuvant intralesional injection. The proposed study herein would serve to improve the level of evidence and to establish the safety and efficacy of combined intralesional TAC+5FU for keloids following surgical excision.
Primary Outcome
Treatment effective if no keloid recurrence is visible by 12 months post treatment
Interventions
- DRUG Triamcinolone Injection
- DRUG Triamcinolone Injection and 5-fluorouracil injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
What the finished NCT04710719 record still lists
NCT04710719 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Triamcinolone Injection is the first listed.
NCT04710719 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04710719 about?
NCT04710719 is a clinical study titled "Post-Surgical Injection With Triamcinolone Versus Triamcinolone/Fluorouracil in Treatment of Keloids". There have been many modalities utilized in the treatment of keloids of the head and neck, however none have been universally successful. The most widely utilized non-surgical intervention is primary intralesional injection with triamcinolone (TAC) which inhibits the proliferation of fibroblasts, in...
What is the current status of trial NCT04710719?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2021-02-01. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04710719?
The interventions under investigation include: Triamcinolone Injection (DRUG), Triamcinolone Injection and 5-fluorouracil injection (DRUG).
Who is sponsoring clinical trial NCT04710719?
This trial is sponsored by Our Lady of the Lake Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04710719's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI